Medicine and Dentistry
Atrial Fibrillation
100%
Cohort Analysis
70%
Apoplexy
57%
Thromboembolism
54%
Venous Thromboembolism
41%
Malignant Neoplasm
31%
Bleeding
24%
Antithrombotic
24%
Hazard Ratio
19%
Valvular Heart Disease
15%
CHA2DS2-VASc Score
15%
Pulmonary Embolism
14%
Anticoagulant Therapy
12%
Vitamin K Antagonist
11%
Brain Ischemia
11%
Maturity Onset Diabetes of the Young
11%
Anticoagulation
10%
Systematic Review
10%
Heart Failure
10%
Diet and Cancer
10%
Phlebothrombosis
10%
Risk Stratification
10%
Diabetes
9%
Adverse Event
8%
Sex Difference
8%
Thromboprophylaxis
7%
Warfarin
7%
Lung Cancer
7%
Patient with Type 2 Diabetes
6%
Proportional Hazards Model
6%
Recurrent Disease
6%
Diabetes Mellitus
6%
Prognostic Factor
6%
Population Research
6%
Cerebral Hemorrhage
6%
Cancer Types
6%
Cancer Treatment
5%
Chronic Kidney Disease
5%
Artery Thrombosis
5%
Drug-Eluting Stent
5%
Cardiovascular System
5%
Obstructive Sleep Apnea
5%
Cardiovascular Disease
5%
Epidemic
5%
Aortic Stenosis
5%
Body Mass Index
5%
Oncologist
5%
Population
5%
Alcohol Consumption
5%
Sinus Rhythm
5%
Keyphrases
Atrial Fibrillation
68%
National Cohort Study
47%
Thromboembolism
30%
Stroke Risk
25%
Thromboembolic Risk
19%
Confidence Interval
14%
High Risk
12%
Hazard Ratio
12%
Risk Modifiers
11%
Female Sex
11%
Aortic Stenosis
10%
Valvular Heart Disease
10%
Type 2 Diabetes Risk
10%
Risk Factors for Stroke
10%
Venous Thromboembolism
10%
Type 2 Diabetes Mellitus (T2DM)
9%
CHA2DS2-VASc Score
9%
Major Bleeding
8%
Anticoagulated Patients
8%
Incident Atrial Fibrillation
7%
Patients with Type 2 Diabetes
7%
Adverse Events
7%
All-cause Mortality
7%
Bleeding
7%
Non-vitamin K Antagonist Oral Anticoagulants
7%
Stroke Prevention
7%
Adjusted Hazard Ratio
6%
Bleeding Risk
6%
Ischemic Stroke
6%
Diabetes Mellitus
6%
Stroke Assessment
6%
Cerebrovascular Ischemia
5%
Traumatic Bleeding
5%
Bleeding Complications
5%
P-terminal Force
5%
Diabetes Duration
5%
Chronic Kidney Disease
5%
Treatment Threshold
5%
Sleep Apnea Diagnosis
5%
Increased Incidence
5%
Cerebrovascular Accident
5%
Cardiovascular Disease
5%
Time-dependent Toxicity
5%
Metastatic Lung Cancer
5%
Oral Anticoagulants
5%
Type 2 Diabetes Prediction
5%
Bleeding Outcomes
5%
Anticoagulation
5%
Invasive Risk
5%
Cerebrovascular Mortality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
83%
Cohort Study
70%
Thromboembolism
57%
Venous Thromboembolism
36%
Anticoagulant Agent
31%
Malignant Neoplasm
29%
Non Insulin Dependent Diabetes Mellitus
20%
Bleeding
11%
Brain Hemorrhage
11%
Brain Ischemia
11%
Antivitamin K
10%
Cardiovascular Disease
10%
Diabetes Mellitus
7%
Warfarin
7%
Recurrent Disease
7%
Lung Cancer
6%
Population Study
5%
Heart Failure
5%
Cancer Recurrence
5%
Aortic Stenosis
5%
Albuminuria
5%
Transient Ischemic Attack
5%
Sleep Disordered Breathing
5%
Heart Atrium Flutter
5%
Valvular Heart Disease
5%
Hormone Receptor
5%
Hemoglobin A1c
5%
